Document is current
Any future updates will be listed below
-
Authors
Renner, Marcus
Oleś, Małgorzata https://orcid.org/0000-0002-1520-1054
Paramasivam, Nagarajan
Heilig, Christoph E. https://orcid.org/0000-0001-8869-1421
Schneider, Annika
Modugno, Caroline
Herremans, Catherine
Hüllein, Jennifer
Hutter, Barbara https://orcid.org/0000-0002-9034-0329
Erkut, Cihan https://orcid.org/0000-0003-4378-9075
Mock, Andreas https://orcid.org/0000-0002-3332-9166
Krieghoff-Henning, Eva
Jensen, Cecilia B.
Sakhteman, Amirhossein
The, Matthew https://orcid.org/0000-0002-5401-5553
Prinz, Tony https://orcid.org/0000-0002-4866-6456
Lajer, Panna
Baude-Müller, Annika
Beck, Katja
Beuthien-Baumann, Bettina
Apostolidis, Leonidas https://orcid.org/0000-0002-6358-8206
Bauer, Sebastian https://orcid.org/0000-0001-5949-8120
Boerries, Melanie https://orcid.org/0000-0002-3670-0602
Brandts, Christian H.
Rieke, Damian T. https://orcid.org/0000-0003-0027-7977
Kindler, Thomas
Klauschen, Frederick https://orcid.org/0000-0002-9131-2389
Schulze-Osthoff, Klaus
Schlenk, Richard F. https://orcid.org/0000-0003-2215-2059
Berchem, Guy
Allgäuer, Michael https://orcid.org/0000-0003-4518-7887
Mechtersheimer, Gunhild
Stenzinger, Albrecht https://orcid.org/0000-0003-1001-103X
Lipka, Daniel B. https://orcid.org/0000-0001-5081-7869
Schlesner, Matthias https://orcid.org/0000-0002-5896-4086
Kuster, Bernhard https://orcid.org/0000-0002-9094-1677
Jahn, Arne https://orcid.org/0000-0003-1045-1908
Schröck, Evelin
Heining, Christoph
Teleanu, Maria-Veronica
Horak, Peter https://orcid.org/0000-0003-4536-9306
Kreutzfeldt, Simon https://orcid.org/0000-0003-3278-4586
Hübschmann, Daniel https://orcid.org/0000-0002-6041-7049
Hartmann, Wolfgang https://orcid.org/0000-0002-7609-5021
Glimm, Hanno https://orcid.org/0000-0003-4104-1135
Fröhling, Stefan https://orcid.org/0000-0001-7907-4595
- License Information
-
More Information
Article History
Received: 25 February 2025
Accepted: 25 March 2026
First Online: 9 April 2026
Competing interests
: M.A. has had an advisory role and received honoraria from AbbVie and Boehringer Ingelheim. G.M. has had an advisory role and received honoraria from Boehringer Ingelheim. D.B.L. has received honoraria from Infectopharm. B.K. is a co-founder and shareholder of OmicScouts and MSAID. He has no operational role in either company. A.J. has received honoraria from AstraZeneca. C.H. has had an advisory role and received honoraria and research funding from Boehringer Ingelheim, Novartis, and Roche. S.F. has had an advisory role and received honoraria from Illumina. The remaining authors declare no competing interests.
